Market Access/ News/ News Allergan gets FDA okay for paediatric Botox use Phil Taylor Allergan, Botox, Dysport, Ipsen, Neuromuscular diseases 0 Comment The FDA has approved Allergan’s Botox to treat lower-limb spasticity in children, further extending the use of the Share X Allergan gets FDA okay for paediatric Botox use https://pharmaphorum.com/news/allergan-gets-fda-okay-for-paediatric-botox-use/
Podcast/ R&D/ Views & Analysis/ Views and analysis Ipsen on neurotoxin research: the pharmaphorum podcast Dominic Tyer Botox, Dysport, Ipsen, migraine, neurotoxins 0 Comment For episode 7 of the pharmaphorum podcast I spoke to Ipsen’s Philippe Picaut about neurotoxin research, with a Share X Ipsen on neurotoxin research: the pharmaphorum podcast https://pharmaphorum.com/r-d/ipsen-neurotoxin-research-podcast/
Allergan, Botox, Dysport, Ipsen, Neuromuscular diseases
0 Comment
